Republican presidential candidate Vivek Ramaswamy and his biotech company & Pfizer! A pharmaceutical company founded by Republican presidential candidate Vivek Ramaswamy is reportedly in talks to sell an experimental drug in a deal that could be valued at more than $7 billion. Roivant Sciences, which Ramaswamy started in 2014, has worked to commercialize drugs held up in development by acquiring them and creating subsidiaries to develop them, according to The Wall Street Journal. Roivant acquired its stomach disease treatment from a deal with Pfizer late last year. https://www.forbes.com/profile/vivek-ramaswamy/?sh=2a58754654cd He was behind the biggest biotechnology initial public offering of 2016, Myovant Sciences, which raised $218 million listing its shares on Nasdaq in October.